Edges in Network
| Network | GSE16446_top8000 - GSE16446 - SiGN-BN NNSR |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | MYL9 |
| Upstream (Parents) |
|---|
| (<<) EFEMP2 → MYL9 |
| (<<) PDLIM7 → MYL9 |
| (<<) TAGLN → MYL9 |
| (<<) MSRB3 → MYL9 |
| (<<) CNN1 → MYL9 |
| (<<) TPM2 → MYL9 |
| Downstream (Children) |
|---|
| MYL9 → PARVA (>>) |
| MYL9 → PPP1R14A (>>) |
| MYL9 → EFEMP2 (>>) |
| MYL9 → TNFRSF12A (>>) |
| MYL9 → PDLIM7 (>>) |
| MYL9 → KCNMB1 (>>) |
| MYL9 → TAGLN (>>) |
| MYL9 → FBLN5 (>>) |
| MYL9 → FERMT2 (>>) |
| MYL9 → MYADM (>>) |
| MYL9 → TPM2 (>>) |
| MYL9 → HCFC1R1 (>>) |
| MYL9 → RRAS (>>) |
| MYL9 → TNFRSF10A (>>) |
